Who
Christine Zedelmayer
Sr. Vice President and COO
Company insider
Files Form 4 as: Sr. Vice President and COO, Equillium.
In numbers
- Trades disclosed
- 120
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $3.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Apr 2020
- Last trade
- 5 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 5 Jun 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Code M | $11K14,584 at $0.785 | filing |
| 5 Jun 2026filed 5 Jun 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Sold | $43K14,584 at $2.93 | filing |
| 5 Jun 2026filed 5 Jun 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —14,584 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —14,584 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Code M | $12K14,584 at $0.79 | filing |
| 5 Jun 2026filed 5 Jun 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Sold | $43K14,584 at $2.93 | filing |
| 28 May 2026filed 29 May 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,292 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —48,512 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —14,583 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,625 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Code M | $5,3237,292 at $0.73 | filing |
| 28 May 2026filed 29 May 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,292 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —48,512 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —14,583 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,625 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Code M | $37K48,512 at $0.77 | filing |
| 28 May 2026filed 29 May 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Sold | $150K55,604 at $2.70 | filing |
| 28 May 2026filed 29 May 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Sold | $542200 at $2.71 | filing |
| 28 May 2026filed 29 May 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Code M | $11K14,583 at $0.785 | filing |
| 28 May 2026filed 29 May 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Code M | $12K15,625 at $0.785 | filing |
News
Leerink Partners Initiates Coverage on Equillium (NASDAQ:EQ)EQ · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Christine Zedelmayer; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.